Turning Point Therapeutics to Host Second Quarter 2019 Conference Call
SAN DIEGO, July 22, 2019 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing novel drugs to address treatment resistance, will report second quarter financial results following the close of U.S. …